CSCVX Fees and Costs — Cornercap Small-Cap Value Fund, Investor Shares

Data updated: 2022-11-17

The net expense ratio is 1.30%: a 0.90% management fee plus 0.40% other expenses. This share class carries a redemption fee of 1.00%. In fiscal 2022 the fund paid $248K in broker commissions, 0.1506% of average net assets, and portfolio turnover was 116%.

CSCVX Fees and Expenses

Annual operating expenses and sales charges of CSCVX. Prospectus, as of July 31, 2022.

Annual operating expenses
Management fee0.90%
12b-1 fee0.00%
Other expenses0.40%
Gross expense ratio1.30%
Fee waiver—
Net expense ratio1.30%
Sales charges
Max front load—
Max deferred load—
Redemption fee1.00%
Expense limitation in place (N-CEN)Yes
Fees waived or reduced during the yearNo
Waived fees subject to recoupmentNo

CSCVX Costs Over Time

On $10,000 invested in CSCVX, assuming 5% a year before costs, total costs come to $899 over 5 years, cutting the return by 1.52% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).

$10,000 investedSell after 1 yearSell after 3 yearsSell after 5 years
Value before costs$10,500$11,576$12,763
Fund expenses (net expense ratio 1.30%)$136$424$732
Trading costs (broker commissions)$16$49$85
Lost growth on money paid in costs$0$23$83
Total costs$152$497$899
Value after costs$10,348$11,080$11,864
Impact on return, per year1.52%1.52%1.52%

CSCVX Trading Costs

Brokerage costs reported on SEC Form N-CEN for the fiscal year ending March 31, 2022.

  • Explicit cost rate (commissions ÷ average net assets): 0.1506%
  • Total broker commissions: $248K
  • Bought from dealers (principal trades, not a cost): —
  • Portfolio turnover (prospectus): 116%
  • Securities lending: none during the year

CSCVX Agency Brokers

Commissions paid.

BrokerAmountShare
INSTINET, LLC$190K76.84%
JONESTRADING$57K23.10%
RBC CAPITAL MARKETS, LLC$1540.06%

For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.